Literature DB >> 24639226

Fluorescence-based laser capture microscopy technology facilitates identification of critical in vivo cytomegalovirus transcriptional programs.

Craig N Kreklywich1, Patricia P Smith, Carmen Baca Jones, Anda Cornea, Susan L Orloff, Daniel N Streblow.   

Abstract

Cytomegalovirus gene expression in highly permissive, cultured fibroblasts occurs in three kinetic classes known as immediate early, early, and late. Infection of these cells results in a predictable transcriptional program leading to high levels of virus production. Infection of other, so-called, nonpermissive cell types results in a transcriptional program that either fails to produce virus particles or production is substantially reduced compared to fibroblasts. We have found that CMV gene expression profiles in tissues from infected hosts differ greatly from those observed in infected tissue culture cells. The number of viral genes expressed in tissues is much more limited, and the number of highly active genes does not correlate with viral DNA load. Additionally, viral gene expression in vivo is tissue selective with no two tissues expressing the exact same viral gene profile. Thus, in vivo CMV gene expression appears to be governed by mechanisms that are still uncharacterized. Cytomegalovirus remains in a persistent phase for the lifetime of the host. During this phase only a limited number of host cells are infected, and it is very difficult to detect CMV gene expression in whole tissues without sub-fractionating infected vs. uninfected cells. Herein, we describe the development of a fluorescence-based laser capture microscopy technique coupled with small sample size microarray analysis to determine the viral gene expression in 50-100 infected cells isolated from frozen RCMV-infected tissue sections.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24639226      PMCID: PMC4347879          DOI: 10.1007/978-1-62703-788-4_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  24 in total

1.  Elimination of donor-specific alloreactivity prevents cytomegalovirus-accelerated chronic rejection in rat small bowel and heart transplants.

Authors:  Susan L Orloff; Daniel N Streblow; Cecilia Soderberg-Naucler; Qiang Yin; Craig Kreklywich; Christopher L Corless; Patricia A Smith; Christopher B Loomis; Lisa K Mills; Judith W Cook; Catherine A Bruggeman; Jay A Nelson; Cynthia R Wagner
Journal:  Transplantation       Date:  2002-03-15       Impact factor: 4.939

2.  High-resolution human cytomegalovirus transcriptome.

Authors:  Derek Gatherer; Sepehr Seirafian; Charles Cunningham; Mary Holton; Derrick J Dargan; Katarina Baluchova; Ralph D Hector; Julie Galbraith; Pawel Herzyk; Gavin W G Wilkinson; Andrew J Davison
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-22       Impact factor: 11.205

3.  Cytomegalovirus latency promotes cardiac lymphoid neogenesis and accelerated allograft rejection in CMV naïve recipients.

Authors:  S L Orloff; Y-K Hwee; C Kreklywich; T F Andoh; E Hart; P A Smith; I Messaoudi; D N Streblow
Journal:  Am J Transplant       Date:  2011-01       Impact factor: 8.086

4.  Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency.

Authors:  Felicia D Goodrum; Craig T Jordan; Kevin High; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-27       Impact factor: 11.205

5.  Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease.

Authors:  J B Muhlestein; B D Horne; J F Carlquist; T E Madsen; T L Bair; R R Pearson; J L Anderson
Journal:  Circulation       Date:  2000-10-17       Impact factor: 29.690

6.  The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome.

Authors:  Andrew J Davison; Aidan Dolan; Parvis Akter; Clare Addison; Derrick J Dargan; Donald J Alcendor; Duncan J McGeoch; Gary S Hayward
Journal:  J Gen Virol       Date:  2003-01       Impact factor: 3.891

7.  Characterization of a novel Golgi apparatus-localized latency determinant encoded by human cytomegalovirus.

Authors:  Alex Petrucelli; Michael Rak; Lora Grainger; Felicia Goodrum
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

8.  Systematic comparison of constitutive promoters and the doxycycline-inducible promoter.

Authors:  Jane Yuxia Qin; Li Zhang; Kayla L Clift; Imge Hulur; Andy Peng Xiang; Bing-Zhong Ren; Bruce T Lahn
Journal:  PLoS One       Date:  2010-05-12       Impact factor: 3.240

9.  Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants.

Authors:  Daniel N Streblow; Craig Kreklywich; Qiang Yin; V T De La Melena; Christopher L Corless; Patricia A Smith; Christina Brakebill; Judith W Cook; Cornelis Vink; Cathrien A Bruggeman; Jay A Nelson; Susan L Orloff
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  Human cytomegalovirus infection and expression in human malignant glioma.

Authors:  Charles S Cobbs; Lualhati Harkins; Minu Samanta; G Yancey Gillespie; Suman Bharara; Peter H King; L Burt Nabors; C Glenn Cobbs; William J Britt
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

View more
  2 in total

1.  HCMV Displays a Unique Transcriptome of Immunomodulatory Genes in Primary Monocyte-Derived Cell Types.

Authors:  Ellen Van Damme; Kim Thys; Marianne Tuefferd; Carl Van Hove; Jeroen Aerssens; Marnix Van Loock
Journal:  PLoS One       Date:  2016-10-19       Impact factor: 3.240

2.  In situ 10-cell RNA sequencing in tissue and tumor biopsy samples.

Authors:  Shambhavi Singh; Lixin Wang; Dylan L Schaff; Matthew D Sutcliffe; Alex F Koeppel; Jungeun Kim; Suna Onengut-Gumuscu; Kwon-Sik Park; Hui Zong; Kevin A Janes
Journal:  Sci Rep       Date:  2019-03-20       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.